| Name | Company Number | Date Appointed | Rating |
|---|---|---|---|
| AZIMUTH PHARMA LIMITED | 07916512 | 15/02/2024 | Silver |
| BIOSCRIPT GROUP LIMITED | 09542360 | 15/02/2024 | Silver |
| BIOSCRIPT HOLDINGS LIMITED | 13203898 | 20/09/2022 | Two Red Flags |
| BIOSCRIPT LIMITED | 13216692 | 02/05/2023 | One Red Flag |
| BIOSCRIPT MIDCO 1 LIMITED | 13208513 | 02/05/2023 | Bronze |
| BIOSCRIPT MIDCO 2 LIMITED | 13212966 | 02/05/2023 | Bronze |
| BIOSCRIPT STIRLING LIMITED | 04354625 | 15/02/2024 | Silver |
| CANCER COMMUNICATIONS AND CONSULTANCY LIMITED | 05049252 | 15/02/2024 | Silver |
| ENZYME COMMUNICATIONS LTD | 10790509 | 26/04/2024 | Silver |
| FORTIS PHARMA CONSULTING LIMITED | 05390470 | 15/02/2024 | Silver |
| MEDOLOGIE LIMITED | 09432933 | 15/02/2024 | Bronze |
| MERIDIAN HEALTHCOMMS HOLDINGS LIMITED | 11350918 | 15/02/2024 | One Red Flag |
| MERIDIAN HEALTHCOMMS LIMITED | 05125119 | 15/02/2024 | Silver |
| PORTLAND MEDICAL COMMUNICATIONS LIMITED | 10382316 | 15/02/2024 | Silver |
| VALID INSIGHT LTD | 08539682 | 15/02/2024 | Silver |
| Name | Company Number | Date Appointed | Date Resigned | Rating |
|---|---|---|---|---|
| BRUNSWICK ARTS CONSULTING LLP | OC306586 | 26/10/2015 | 03/11/2017 | Bronze |
| BRUNSWICK CONSULTING LLP | OC306582 | 26/10/2015 | 03/11/2017 | Bronze |
| BRUNSWICK CORPORATE ADVISORY LLP | OC306585 | 26/10/2015 | 03/11/2017 | Bronze |
| BRUNSWICK FINANCIAL ADVISORY LLP | OC306584 | 26/10/2015 | 03/11/2017 | Bronze |
| BRUNSWICK MINSTER LLP | OC306588 | 26/10/2015 | 03/11/2017 | Bronze |
| BRUNSWICK PUBLIC RELATIONS LLP | OC306583 | 26/10/2015 | 03/11/2017 | Bronze |
| CANTOS COMMUNICATIONS LLP | OC306587 | 26/10/2015 | 03/11/2017 | Bronze |
| CHS HEALTHCARE HOLDINGS LIMITED | 09628817 | 21/01/2019 | 24/02/2021 | Silver |
| GENFLOW BIOSCIENCES PLC | 13138531 | 17/01/2022 | 29/06/2022 | Amber |
| MERCHANTCANTOS LLP | OC305693 | 26/10/2015 | 03/11/2017 | Bronze |